IE
SCNI

Israel Englander’s Scinai Immunotherapeutics SCNI Stock Holding History

Israel Englander’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-106
Closed -$5.48K – 6460
2024
Q1 		$5.48K Buy
+106
New +$5.47K ﹤0.01% 5997
2023
Q3 		– Sell
-116
Closed -$15.7K – 6506
2023
Q2 		$15.7K Sell
116
-320
-73% -$55.3K ﹤0.01% 5672
2023
Q1 		$94K Buy
+436
New +$108K ﹤0.01% 5445
2022
Q4 		– Sell
-12
Closed -$9K – 6994
2022
Q3 		$9K Buy
+12
New +$13.5K ﹤0.01% 6686
2022
Q2 		– Sell
-20
Closed -$34K – 7432
2022
Q1 		$34K Buy
+20
New +$29K ﹤0.01% 6513
2021
Q3 		– Sell
-12
Closed -$33K – 7194
2021
Q2 		$33K Buy
+12
New +$37.4K ﹤0.01% 6402

Other funds holding SCNI

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
MSG
Main Street Group Glen Allen, Virginia $429M AUM 34.03% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Israel Englander's SCNI Position: Q2 2024 in Review

Israel Englander sold out of Scinai Immunotherapeutics (SCNI) in Q2 2024, closing a stake of 106 shares — an estimated $5.48K sold.

Israel Englander first reported a position in SCNI in Q2 2021 and held it in 6 quarters. The position peaked at $94K in Q1 2023. 9 funds tracked by Wall St. Rank hold SCNI as of Q2 2024.

  • Israel Englander reported no remaining Scinai Immunotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Israel Englander sold 106 Scinai Immunotherapeutics shares in Q2 2024, an estimated $5.48K.
  • Israel Englander first reported a position in Scinai Immunotherapeutics in Q2 2021 and held it in 6 quarters.
  • Israel Englander's Scinai Immunotherapeutics position peaked at $94K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.